Rankings
▼
Calendar
ZTS Q1 2016 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
Gross Profit
$773M
66.5% margin
Operating Income
$347M
29.9% margin
Net Income
$204M
17.6% margin
EPS (Diluted)
$0.41
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$6M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$7.5B
Total Liabilities
$6.3B
Stockholders' Equity
$1.2B
Cash & Equivalents
$675M
Revenue Segments
Dogs and Cats
$427M
37%
Cattle
$377M
33%
Swine
$146M
13%
Poultry
$122M
11%
Horses
$39M
3%
Fish
$38M
3%
Geographic Segments
UNITED STATES
$582M
51%
International
$567M
49%
← FY 2016
All Quarters
Q2 2016 →